A recent study demonstrated that a machine learning-based model significantly improves the differentiation between non-neoplastic and neoplastic gallbladder polyps. Analyzing data from 744 patients, the combined model achieved an AUC of 0.910, compared to lower scores from individual models, thus reducing unnecessary cholecystectomies. Notably, the polyp short diameter emerged as a critical predictor of neoplastic […]
Category: HPB & Spleen
Minimally invasive liver surgery shows superior short-term outcomes
A Belgian registry of 1342 liver resections found that minimally invasive liver surgery (MILS) was preferred in 51% of cases. MILS patients had better short-term outcomes compared to open surgery, including shorter surgery times, less blood loss, and lower complication rates. Notably, centers performing more than 50 resections annually exhibited significantly improved outcomes. MILS was […]
Predictive model identifies risk factors for conversion in surgery
Conversion rates during minimally invasive left pancreatectomy (MILP) reached 15.6% in a study of 2,104 patients across 55 centers. Key risk factors included male sex, BMI over 25 kg/m², a history of laparotomy, initial pancreatitis, and larger tumor size. A conversion risk score (CRS) was developed based on these preoperative variables, allowing scores from 2% […]
Liver expert panels significantly improve treatment eligibility for patients.
An expert panel’s re-evaluation of colorectal liver metastases led to a notable increase in treatment eligibility. Initially, only 29% of patients were deemed resectable before systemic treatment, but this figure rose to 68% following multiple assessments. Alarmingly, nearly 29% of patients recognized as resectable were not referred for local treatment. This highlights the critical role […]
A new prognostic tool improves outcomes in liver cancer patients
A novel prognostic tool, the Weighted Alpha-Fetoprotein Tumor Burden Score (WATS), has demonstrated enhanced predictive capabilities for hepatocellular carcinoma patients post-resection. In a study involving 772 patients, WATS outperformed existing staging systems, offering reliable assessments of progression-free survival and overall survival across various time frames. Its formula incorporates tumor number, size, and alpha-fetoprotein levels, providing […]
Unique barriers identified for marginalized HCC patients
Marginalized groups, particularly black patients and those affected by adverse social determinants of health, encounter significant barriers to curative treatments for hepatocellular carcinoma (HCC). Research revealed common challenges, such as information overload and communication gaps, while black patients also faced psychological burdens and systemic distrust. Conversely, patients experiencing adverse social determinants reported financial instability and […]
Multidisciplinary approaches improve pancreatic cancer management
Findings emphasize the need for multidisciplinary evaluations in pancreatic ductal adenocarcinoma (PDAC) management, with only 20% of patients eligible for curative surgery at diagnosis. Preoperative imaging techniques, particularly CT and EUS, are essential for accurate staging and vascular assessment. The review underscores the importance of tailored approaches across disease stages, including endoscopic drainage methods and […]
New therapies improve survival rates for pancreatic cancer patients
Pancreatic cancer remains a leading global cause of death, exacerbated by aging demographics and rising risk factors like obesity and smoking. Despite its generally poor prognosis, advancements in treatment have emerged, particularly through neoadjuvant therapies, targeted therapies based on genetic testing, and immune checkpoint inhibitors. Minimally invasive surgical techniques have enhanced the safety and efficacy […]
Liver resection outperforms radiofrequency ablation for small tumors
A systematic review and meta-analysis comparing liver resection (LR) and radiofrequency ablation (RFA) for solitary hepatocellular carcinoma (HCC) ≤3 cm highlights that LR offers superior overall survival, disease-free survival, and recurrence-free survival compared to RFA, particularly for lesions ≤2 cm. While no significant differences were found in randomized controlled trials, cohort studies indicated LR’s advantages, […]
External-beam radiation therapy improves outcomes in liver cancer patients
Recent findings reveal that external-beam radiation therapy (EBRT) significantly enhances patient outcomes in hepatocellular carcinoma, addressing critical care gaps. Randomized trials show that EBRT boosts overall survival and recurrence-free survival compared to conventional treatments, particularly when combined with sorafenib. Additionally, it improves the quality of life for patients with painful tumors. As technology advances, guidelines […]